Skip to main navigation Skip to search Skip to main content

CCR8 Immunohistochemistry Highlights CCR8 as a Diagnostic and Therapeutic Biomarker in Cutaneous T-Cell Lymphoma

  • Shamir Geller*
  • , Viviane Liao
  • , Andrea Moy
  • , Travis J. Hollmann
  • , Melissa Pulitzer
  • *Corresponding author for this work
  • Memorial Sloan-Kettering Cancer Center
  • Bristol-Myers Squibb

Research output: Contribution to journal › Article › peer-review

3 Scopus citations
Original languageEnglish
Pages (from-to)3231-3233.e2
JournalJournal of Investigative Dermatology
Volume145
Issue number12
DOIs
StatePublished - Dec 2025
Externally publishedYes

Funding

FundersFunder number
National Institutes of Health
National Cancer InstituteP30 CA008748

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Adult T-cell leukemia/lymphoma
    • Anaplastic large cell lymphoma
    • CD8+ aggressive epidermotropic T-cell lymphoma
    • Mycosis fungoides
    • Sezary syndrome

    Cite this